Its purpose is to assess how effectively the therapy reduces feelings of depression. Individuals with multiple unexplained physical symptoms may be eligible to participate in the somatization treatment study. It involves 10 weekly sessions of a cognitive behavior therapy that teaches patients methods for reducing their discomfort and coping with their symptoms. Participants will be evaluated before treatment, after it is completed and again six and 12 months later. Eligible participants will receive physical examinations by board-certified dermatologists, laboratory tests and medication at no cost.
Some programs have monetary compensation.
To be eligible, the participants must be between the ages of 30 and 70, have Type II diabetes, high blood pressure and protein in their urine. The purpose of the study is to determine the investigational medication's ability to reduce the rate of progression of renal disease and other problems associated with diabetic nephropathy. The second study is to compare the ability of an investigational medication to reduce the amount of protein in the urine with a medication currently on the market to treat high blood pressure. The study is for 16 weeks and those eligible must be 18 or older with hypertension and Type II diabetes. For both studies, participants will receive study medications, physical exams, blood pressure monitoring and laboratory tests, EKGs and chest x-rays at no cost.